# Versatile Ampification Single-Molecule Detection in Liquid Biopsy

> **NCT05940311** · — · RECRUITING · sponsor: **Regina Elena Cancer Institute** · enrollment: 20 (estimated)

## Conditions studied

- Liquid Biopsy
- Melanoma (Skin)
- Melanoma Stage III
- Melanoma Stage IV

## Interventions

- **PROCEDURE:** Blood sampling in addition to the blood normally required for their clinical management
- **PROCEDURE:** Blood plasma and circulating tumor DNA (ctDNA)

## Key facts

- **NCT ID:** NCT05940311
- **Lead sponsor:** Regina Elena Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-04-27
- **Primary completion:** 2024-11-30
- **Final completion:** 2026-03-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2024-11-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05940311

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05940311, "Versatile Ampification Single-Molecule Detection in Liquid Biopsy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05940311. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*